Skip to main content

Table 1 Study outcomes, measures, and patient characteristics

From: Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease

No. Outcomes, Measures & Characteristics Data Source by Outcome Timeline and Frequency
Baseline Pre-Visit Post-Visit Three Months
1 Primary Outcome Patient Knowledge    
  Anemia Knowledge Patient Anemia Knowledge in Kidney Disease (PAKKD) [19] X X X
2 Secondary Outcomes Patient Satisfaction    
  Provider Communication Satisfaction Satisfaction with Provider Communications (CAT) [20]   X  
  Health Decision Certainty Decisional Conflict Scale (DCS) [21]   X  
  Perceived Communication Efficacy Perceived Efficacy in Patient-Physician Interactions (PEPPI) [22]   X X
3 Subject Characteristics Potential Co-Variables/Modifiers    
  Patient Demographic Information Demographic Form X   X
  Patient Numeracy Assessments Schwartz Risk Numeracy Test [27] X   
  Anemia Symptoms Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) [28] X   X
  Medical Outcomes Patient Electronic Medical Record Hemoglobin Lab Values X   X